Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer

@inproceedings{Kawamura2018MulticenterPI,
  title={Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer},
  author={Junichiro Kawamura and Fumiaki Sugiura and Yasushi Sukegawa and Yasumasa Yoshioka and Jin-ichi Hida and Shoichi Hazama and Kiyotaka Okuno},
  booktitle={Oncology letters},
  year={2018}
}
The safety and immunological responsiveness of a peptide vaccine of ring finger protein 43 and 34-kDa translocase of the outer mitochondrial membrane combined with uracil-tegafur/leucovorin (UFT/LV) was previously demonstrated in metastatic colorectal cancer (CRC) in a phase I clinical trial. To clarify the survival benefit of a peptide vaccine combined… CONTINUE READING